Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-09-29
2000-05-16
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 31715
Patent
active
060637730
ABSTRACT:
The present invention relates to a method of reducing the risk of infections and the risk of conception. In particular, the invention relates to cellulose sulfate having contraceptive and anti-microbial properties. Cellulose sulfate may be administered in appropriate dosage forms to reduce the risk of infections or the risk of conception. It can also be used during sexual contact to concomitantly reduce the risk of conception and the risk of sexually transmitted diseases.
REFERENCES:
patent: 4840941 (1989-06-01), Ueno et al.
patent: 5288704 (1994-02-01), Ungheri et al.
Astrup, T. and Alkjaersig, N. (1950) Polysaccharide polysulphuric acids as antihyaluronidases. Nature 166: 568-569.
Spensley, P.C. and Rogers, H.J. (1954) Enzyme Inhibition. Nature 173:1190.
Doring, G.K. (1954) Practical experience with a new vaginal contraceptive. Int. J. Sexol. 8:93-94.
Wood, S.G., Forrest M.E., John, B.A., Chasseaud, L.F. and van de Wiel, J.A.C. (1984) Extent of vaginal absorption of sulphated polysaccharide from A-gen 53 in the rabbit. Contraception 29: 375-383.
Andolz, P., Palazon, X. and Bielsa, M.A. (1983) Estudio del efecto de una nueva asociacion contraceptiva sobre los expermatozozoides humanos. Gine-Dips 11: 1-14.
Hildebrandt, A. (1956) Praktische erfahrungen mit einem fermentchemischen antikonzipiens. Medizinisch Klinik 51: 1192.
Ziegeler, H. (1960) Geburtenkontrolle durch A-GEN 53. Med. Welt 41: 2181.
Martinez-Sausor, V. and Royo A.P. (1984) Estudio de la eficacia y aceptabilldad de un spermicida espermostatico/vaginal en ovulos en portadoras de un disositivo intrauterino. El Medico 91: 82.
Remington's Pharmaceutical Sciences 17.sup.th Ed 1985 p. 1158.
Mizumoto et al. "Sulfated homopolysaccharides with immunomodulating activities are more potent anti-HTLV-III agents thatn sulfated heteropolysaccharides " vol. 58, No. 3, 1988.
Yamamoto et al: "synthesis, structure and antiviral activity of sulfates of cellulose and its branched derivatives", vol. 14, No. 1, 1990, pp. 53-64, XP000160254.
Rothschild et al: "endotoxin shock in dogs pretreated with cellulose sulfate" vol. 20, No. 1, 1967, pp. 77-78, XP000645736.
Dunn et al: the reponse of the newborn rat to injury: vol. 116, No. 3, 1975, pp. 165-181, XP000645733.
Zuffrey et al: "risques vrais et faux de la contraception locale" vol. 14, No. 3, 1985, pp. 359, 363, XP000645734.
Zuffrey et al, 1985 J. Gynecol, Obstet Biol Reprod vol. 14 pp. 359-363.
Polsly et al 1988, The Lancet, Jun. 25, p. 1456.
Asculai et al, 1978, Antimicrobial Agent & Chemother vol. 13 (4) pp. 686-690.
Anderson Robert A.
Usher Thomas C.
Zaneveld Lourens J. D.
Polydex Pharmaceuticals Ltd.
Rush-Presbyterian-St. Luke's Medical Center
Travers Russell
LandOfFree
Cellulose sulfate for use as antimicrobial and contraceptive age does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cellulose sulfate for use as antimicrobial and contraceptive age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cellulose sulfate for use as antimicrobial and contraceptive age will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-259025